[HTML][HTML] Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis

T Didari, S Mozaffari, S Nikfar… - World journal of …, 2015 - ncbi.nlm.nih.gov
METHODS: PubMed, Cochrane library, Scopus, Google Scholar, and Clinicaltrial. gov
databases were searched for literature published between September 2007 and December …

Efficacy and safety of probiotics in irritable bowel syndrome: a systematic review and meta-analysis

B Li, L Liang, H Deng, J Guo, H Shu… - Frontiers in …, 2020 - frontiersin.org
Background Irritable bowel syndrome is a functional gastrointestinal disease. Evidence has
suggested that probiotics may benefit IBS symptoms. However, clinical trials remain …

[HTML][HTML] Off-label uses of selective serotonin reuptake inhibitors (SSRIs)

TB Jannini, GD Lorenzo, E Bianciardi… - Current …, 2022 - ncbi.nlm.nih.gov
Psychiatric drugs have primacy for off-label prescribing. Among those, selective serotonin
reuptake inhibitors (SSRIs) are highly versatile and, therefore, widely prescribed. Moreover …

[HTML][HTML] Pharmacological approach for managing pain in irritable bowel syndrome: a review article

L Chen, SJ Ilham, B Feng - Anesthesiology and Pain Medicine, 2017 - ncbi.nlm.nih.gov
Results Certain conventional pain managing drugs do not effectively improve IBS symptoms,
including NSAIDs, acetaminophen, aspirin, and various narcotics. Anxiolytic and …

Lubiprostone is effective in the treatment of chronic idiopathic constipation and irritable bowel syndrome: a systematic review and meta-analysis of randomized …

F Li, T Fu, WD Tong, BH Liu, CX Li, Y Gao, JS Wu… - Mayo Clinic …, 2016 - Elsevier
Objective To evaluate the efficacy and safety of lubiprostone in the treatment of chronic
idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C) …

Antidepressants for irritable bowel syndrome—A systematic review

A Kułak-Bejda, G Bejda, N Waszkiewicz - Pharmacological Reports, 2017 - Elsevier
Background According to the multifactorial etiology of Irritable bowel syndrome (IBS),
psychological factors play an important role. It is possible that antidepressant therapy may …

A Network Pharmacology‐Based Study on Irritable Bowel Syndrome Prevention and Treatment Utilizing Shenling Baizhu Powder

M Meng, C Bai, B Wan, L Zhao, Z Li… - BioMed Research …, 2021 - Wiley Online Library
Background and Objective. Irritable bowel syndrome (IBS) is a prevalent disorder of the
gastrointestinal system with complex pathogenesis. Shenling Baizhu powder (SLBZP) is a …

Phase II drugs under clinical investigation for the treatment of chronic constipation

S Mozaffari, T Didari, S Nikfar… - Expert Opinion on …, 2014 - Taylor & Francis
Introduction: Chronic constipation (CC) is a common gastrointestinal (GI) motility disorder
that significantly impairs the quality of life in affected subjects. As almost half of the patients …

Mixed MOP/DOP agonist biphalin elicits anti-transit effect in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms

M Zielińska, A Jarmuż, M Sałaga, AW Lipkowski… - Pharmacological …, 2016 - Elsevier
Background Opioid receptors play a crucial role in the maintenance of homeostasis in the
gastrointestinal (GI) tract. The aim of this study was to characterize the effect of biphalin, a …

Drug discovery approaches to irritable bowel syndrome

PJ Hornby - Expert opinion on drug discovery, 2015 - Taylor & Francis
Introduction: Irritable bowel syndrome (IBS) is defined by symptoms of abdominal pain and
altered bowel habits without detectable organic disease. Antidepressants and serotonin …